Patent · US Active

Morpholino oligonucleotide manufacturing method

US9790497B2 · kind B2 · utility

3Cited by
7References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 2015
Grant dateOct 17, 2017
Priority date
Expiry dateNov 20, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Using a morpholino nucleotide wherein 5′-hydroxy group or a hydroxy group present on the substituent of the 5′-hydroxy group is protected by a protecting group having an alkyl group having not less than 10 and not more than 300 carbon atoms and/or an alkenyl group having not less than 10 and not more than 300 carbon atoms as a starting material, a method capable of efficiently producing the morpholino oligonucleotide in a high yield by a liquid phase synthesis can be provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.